Overview

18F-AraG PET/CT as a Non-Invasive Imaging Biomarker for Chemoradiation Treatment Response in Esophageal Cancer

Status:
RECRUITING

Trial end date:
2027-10-01

Target enrollment:

Participant gender:

Summary

To learn if 18F-FAraG PET scans can find tumors in participants with esophageal cancer and predict a participant's response to treatment.

Phase:

PHASE1

Details

Lead Sponsor:

M.D. Anderson Cancer Center